Additional file 1: of Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients Nicola Gianotti Andrea Poli Silvia Nozza Laura Galli Nadia Galizzi Marco Ripa Marco Merli Alessia Carbone Vincenzo Spagnuolo Adriano Lazzarin Antonella Castagna 10.6084/m9.figshare.c.3932917_D1.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Durability_of_switch_regimens_based_on_rilpivirine_or_on_integrase_inhibitors_both_in_association_with_tenofovir_and_emtricitabine_in_HIV-infected_virologically_suppressed_patients/5611495 Specific PIs and NNRTIs ongoing at baseline. (DOCX 12 kb) 2017-11-16 05:00:00 Rilpivirine Raltegravir Elvitegravir/cobicistat Dolutegravir Non-nucleoside reverse transcriptase inhibitors Integrase inhibitors Switch regimen Residual viremia Virological suppression